Abstract:Aims/hypothesis: Myeloid-derived growth factor (MYDGF), mainly secreted by bone marrow-derived cells, has been known to promote glucagon-like peptide-1 production and improve glucose/lipid metabolism in mouse models of diabetes, but little is known about the functions of MYDGF in diabetic kidney disease (DKD). Here, we investigated whether MYDGF can prevent the progression of DKD. Methods: In vivo experiments, both loss- and gain-of-function strategies were used to evaluate the effect of MYDGF on albuminuria and pathological glomerular lesions. We used streptozotocin-treated Mydgf knockout and wild-type mice on high fat diets to induce a model of DKD. Then, albuminuria, glomerular lesions and podocyte injury were evaluated in Mydgf knockout and wild-type DKD mice treated with adeno-associated virus-mediated Mydgf gene transfer. In vitro and ex vivo experiments, the expression of slit diaphragm protein nephrin and podocyte apoptosis were evaluated in conditionally immortalised mouse podocytes and isolated glomeruli from non-diabetic wild-type mice treated with recombinant MYDGF. Results: MYDGF deficiency caused more severe podocyte injury in DKD mice, including the disruption of slit diaphragm proteins (nephrin and podocin) and an increase in desmin expression and podocyte apoptosis, and subsequently caused more severe glomerular injury and increased albuminuria by 39.6% compared with those of wild-type DKD mice (p < 0.01). Inversely, MYDGF replenishment attenuated podocyte and glomerular injury in both wild-type and Mydgf knockout DKD mice and then decreased albuminuria by 36.7% in wild-type DKD mice (p < 0.01) and 34.9% in Mydgf knockout DKD mice (p < 0.01). Moreover, recombinant MYDGF preserved nephrin expression and inhibited podocyte apoptosis in vitro and ex vivo. Mechanistically, the renoprotection of MYDGF was attributed to the activation of the Akt/Bcl-2-associated death promoter (BAD) pathway. Conclusions/interpretation: The study demonstrates that MYDGF protects podocytes from injury and prevents the progression of DKD, providing a novel strategy for the treatment of DKD. Graphical abstract.

Intravenous administration of hepatocyte growth factor gene ameliorates diabetic nephropathy in mice.

Hepatocyte Growth Factor Gene Therapy Slows Down the Progression of Diabetic Nephropathy in db/db Mice

HGF protected against diabetic nephropathy via autophagy-lysosome pathway in podocyte by modulating PI3K/Akt-GSK3β-TFEB axis.

Hepatocyte growth factor ameliorates progression of interstitial injuries in tubular epithelial cells.

[The Renal Protective Effect and Mechanism of Liraglutide in Diabetic Mice Induced by High-Fat Diet].

Attenuation Of Experimental Liver Fibrosis By Hepatocyte Growth Factor Gene Delivery Mediated By Adenovirus

Intraperitoneal Administration of the Globular Adiponectin Gene Ameliorates Diabetic Nephropathy in Wistar Rats

G-CSF Prevents Progression of Diabetic Nephropathy in Rat

MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney disease

Hederagenin improves renal fibrosis in diabetic nephropathy by regulating Smad3/NOX4/SLC7A11 signaling-mediated tubular cell ferroptosis

HGF Protects Rat Mesangial Cells from High-Glucose-mediated Oxidative Stress.

FGF1ΔHBS delays the progression of diabetic nephropathy in late-stage type 2 diabetes mouse model by alleviating renal inflammation, fibrosis, and apoptosis

HGF gene therapy attenuates renal allograft scarring by preventing the profibrotic inflammatory-induced mechanisms

Hepatocyte Growth Factor Alleviates Hepatic Insulin Resistance and Lipid Accumulation in High‐fat Diet‐fed Mice

IGF-1R Inhibitor Ameliorates Diabetic Nephropathy with Suppressed HMGN1/TLR4 Pathway

HGF Alleviates High Glucose-Induced Injury in Podocytes by GSK3β Inhibition and Autophagy Restoration.

Hepatocyte growth factor suppresses transforming growth factor-beta-1 and type III collagen in human primary renal fibroblasts.

Intravenous Injection of Nrf2 Plasmid Attenuates Glomerular ROS Injury of Diabetic Mice

Hepatocyte Growth Factor-Induced Amelioration in Renal Interstitial Fibrosis is Associated with Reduced Expression of Alpha-Smooth Muscle Actin and Transforming Growth Factor-Beta1.

Effect of astragalus membranaceus on HGF by renalinterstitial fibroblasts in the high glucose

Hepatocyte Growth Factor-Induced Amelioration in Chronic Renal Failure is Associated with Reduced Expression Ofα-Smooth Muscle Actin